Biocryst Pharma Inc (NQ: BCRX )

10.78 USD +0.31 (+2.96%)

Official Closing Price Updated: 7:59 PM EST, Feb 26, 2021 Add to My Watchlist

Price and Volume

Volume	4,942,400
Open	10.88
Bid (Size)	10.78 (1)
Ask (Size)	10.84 (42)
Prev. Close	10.47
Today's Range	10.29 - 11.09
52wk Range	1.580 - 12.90
Shares Outstanding	98,716,856
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

BioCryst Receives Positive CHMP Opinion for ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema

February 25, 2021

BioCryst Reports Fourth Quarter and Full Year 2020 Financial Results and Upcoming Key Milestones

February 25, 2021

Performance

YTD	+46.07%	+46.07%
1 Month	+23.06%	+23.06%
3 Month	+110.14%	+110.14%
6 Month	+171.54%	+171.54%
1 Year	+293.43%	+293.43%

More News

BioCryst to Present at Upcoming Investor Conferences

February 18, 2021

BioCryst to Report Fourth Quarter and Full Year 2020 Financial Results on February 25

February 11, 2021

BioCryst to Present Data at 2021 American Academy of Allergy, Asthma & Immunology Annual Meeting

February 09, 2021

Is it the right moment for investing in BioCryst Pharmaceuticals shares?

February 03, 2021

BioCryst Announces FDA Approval of Supplemental New Drug Application for RAPIVAB® Expanding Patient Population to Include Children Six Months and Older

February 03, 2021

Thinking about buying stock in Powerbridge Technologies, BioCryst Pharma, Oramed Pharma, Ampio Pharma, or Plus Therapeutics?

February 26, 2021

BioCryst's Orladeyo Wins EU Positive Opinion For Hereditary Angioedema

February 26, 2021

12 Health Care Stocks Moving In Thursday's Pre-Market Session

February 25, 2021

Why BioCryst Pharmaceuticals Stock Is Falling Today

February 25, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.